Proposed FDA Rule Targets Asbestos in Talc Cosmetic Products
By India Edwards HealthDay Reporter
FRIDAY, Dec. 27, 2024 -- The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.
According to an FDA report, the proposed rule would mandate that manufacturers test each batch of talc-containing cosmetic products using advanced microscopy techniques, including polarized light and transmission electron microscopy.
Failure to comply with these testing or record-keeping requirements would result in the products being classified as adulterated under the Federal Food, Drug, and Cosmetic Act.
Asbestos contamination in talc-based cosmetics has been a long-standing health concern.
The FDA emphasized there is no safe level of asbestos exposure, and this rule aims to reduce harmful exposure and protect consumers from potential health risks.
The FDA’s announcement comes as Johnson & Johnson faces lawsuits from over 62,000 claimants alleging asbestos in its talc products caused cancer.
The company has denied the allegations, calling its products safe, and is working to resolve claims through a $10 billion settlement in bankruptcy.
The proposed rule is now open for public and industry comments for 90 days before being finalized, according to a news release from CNN.
Sources
- U.S. Food and Drug Administration (FDA), news release, Dec. 26, 2024
- CNN
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Lab Experiments Show Why Wrinkles Form
THURSDAY, July 24, 2025 — The struggle to tame wrinkles is an age-old conflict, with people using any number of lotions, creams and treatments to try and smooth their...
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
WEDNESDAY, July 23, 2025 -- The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research...
Tuna Recalled in Seven States Over Listeria Fears
WEDNESDAY, July 23, 2025 — Two types of tuna sold in seven states are being recalled due to listeria concerns. The first recall affects tuna salad and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.